ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,833,267 | -31.4% | 907,558 | +0.2% | 0.01% | -37.5% |
| Q2 2023 | $2,670,945 | +57.8% | 905,405 | +63.1% | 0.01% | +14.3% |
| Q2 2022 | $1,693,000 | -83.7% | 555,000 | -27.7% | 0.01% | -82.9% |
| Q1 2022 | $10,369,000 | +961.3% | 768,100 | +924.1% | 0.04% | +925.0% |
| Q4 2021 | $977,000 | -52.1% | 75,000 | -62.3% | 0.00% | -55.6% |
| Q2 2021 | $2,038,000 | -75.0% | 199,000 | -55.1% | 0.01% | -76.3% |
| Q1 2021 | $8,155,000 | – | 443,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |